| 번호 | 제목 | 작성일 | 첨부 | 조회 |
| * |
주요 백신 임상 논문들(Updated at 2020.1.29) |
2021-02-02 |
|
1899 |
| 64 |
Post-acute COVID-19 syndrome |
2021-05-27 |
|
2389 |
| 63 |
Moderna 1차 접종 후 발생한 Allergic Reactions 에 대한 미국 CDC 발표 자료 |
2021-02-16 |
|
1161 |
| 62 |
주요 백신 임상 논문들_2020.12.17 |
2020-12-17 |
|
5749 |
| 61 |
역학 review article (systemic review, meta analysis 포함) |
2020-11-30 |
|
2141 |
| 60 |
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial (The Lancet Infectious Disease, Published: November 17, 2020) |
2020-11-30 |
|
895 |
| 59 |
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial (The Lancet Infectious Disease, Published: November 17, 2020) |
2020-11-30 |
|
660 |
| 58 |
예방 및 백신 review article (systemic review, meta analysis 포함) |
2020-11-19 |
|
1415 |
| 57 |
치료 review article (systemic review, meta analysis 포함) |
2020-11-19 |
|
1192 |
| 56 |
임상양상 review article (systemic review, meta analysis 포함) |
2020-11-19 |
|
1005 |
| 55 |
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19 (The New England Journal of Medicine, 2020년 10월 21일 publish) |
2020-11-16 |
|
834 |
| 54 |
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19 (The New England Journal of Medicine, 2020년 10월 28일 publish) |
2020-11-16 |
|
860 |
| 53 |
COVID-19 논문 정리 - 국내 저자 (2020-07-30) |
2020-07-31 |
|
4380 |
| 52 |
COVID-19 논문 정리 - 국내 저자 (2020-07-01) |
2020-07-01 |
|
2511 |
| 51 |
COVID-19 논문 정리 - 국내 저자 (2020-06-15) |
2020-06-16 |
|
1930 |
